Today, a Director at Joint Corp (NASDAQ: JYNT), Ronald Davella, sold shares of JYNT for $26.34K.
Following Ronald Davella’s last JYNT Sell transaction on March 30, 2016, the stock climbed by 5.6%. In addition to Ronald Davella, one other JYNT executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Joint Corp’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $7.56 million and GAAP net loss of $42.78K. In comparison, last year the company earned revenue of $6.01 million and had a GAAP net loss of $1.01 million. The Company has a Price to Book ratio of 89.3695. Currently, Joint Corp has an average volume of 46.63K.
In the last 30 days, insiders have sold $26.34K worth of JYNT shares and purchased $87.3K worth of JYNT shares. The insider sentiment on Joint Corp has been neutral according to 12 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Joint Corp. (United States) engages in the development, ownership, operation, support and management of chiropractic clinics. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment comprises of the operating activities of the company owned or managed clinics.
